Trademark: 86960806
Word
BELTREGA
Status
Dead
Status Code
606
Status Date
Monday, October 28, 2019
Serial Number
86960806
Mark Type
4000
Filing Date
Friday, April 1, 2016
Published for Opposition
Tuesday, August 2, 2016
Abandoned Date
Monday, October 28, 2019

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Oct 28, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 28, 2019
Abandonment - No Use Statement Filed
Mar 28, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 27, 2019
Extension 5 Granted
Mar 22, 2019
Extension 5 Filed
Mar 27, 2019
Case Assigned To Intent To Use Paralegal
Mar 22, 2019
Teas Extension Received
Sep 25, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 21, 2018
Extension 4 Granted
Sep 21, 2018
Extension 4 Filed
Sep 21, 2018
Teas Extension Received
Mar 28, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 26, 2018
Extension 3 Granted
Mar 26, 2018
Extension 3 Filed
Mar 26, 2018
Teas Extension Received
Sep 26, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 23, 2017
Extension 2 Granted
Sep 23, 2017
Extension 2 Filed
Sep 23, 2017
Teas Extension Received
Mar 28, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2017
Extension 1 Granted
Mar 25, 2017
Extension 1 Filed
Mar 25, 2017
Teas Extension Received
Sep 27, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2016
Published For Opposition
Jul 13, 2016
Notification Of Notice Of Publication E-Mailed
Jun 22, 2016
Approved For Pub - Principal Register
Jun 21, 2016
Assigned To Examiner
Apr 6, 2016
New Application Office Supplied Data Entered In Tram
Apr 5, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24